Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L5 pseudogene 14 (RPL5P14) is a processed pseudogene derived from the ribosomal protein L5 (RPL5) gene. Pseudogenes are genetic elements that resemble functional genes but contain mutations or deletions rendering them non-functional; they do not produce active proteins and generally have no direct biological function. RPL5P14 does not encode a protein and is not involved in ribosome biogenesis, disease mechanisms, or drug targeting. Its designation is used in genomic and comparative studies to track gene family evolution, but it does not serve as a therapeutic target or biomarker[1][2][4].\n\nKey clarification: While ribosomal protein L5 (the parent/functional gene of this pseudogene) is an important ribosomal component involved in protein synthesis and described in detail for disease roles such as Diamond-Blackfan anemia[3][5][6][7], RPL5P14 itself is not used as a protein target, marker, nor does it have a biological or therapeutic role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L5 pseudogene 14 (RPL5P14).